Annika Y. Claßen

Sarilumab in patients admitted to hospital with severe or critical COVID-19: a randomised, double-blind, placebo-controlled, phase 3 trial

François-Xavier Lescure, Hitoshi Honda, Robert Fowler et al. · The Lancet Respiratory Medicine · 2021 · 248 citations · Full text

Medicine, Immunology, Pharmacotherapy +17

Primary prophylaxis of bacterial infections and Pneumocystis jirovecii pneumonia in patients with hematologic malignancies and solid tumors: 2020 updated guidelines of the Infectious Diseases Working Party of the German Society of Hematology and Medical Oncology (AGIHO/DGHO)

Annika Y. Claßen, Larissa Henze, Marie von Lilienfeld‐Toal et al. · Annals of Hematology · 2021 · 92 citations · Full text

Medicine, Infectious Diseases, Oncology +17

Phage Therapy in Germany—Update 2023

Christian Willy, Joachim J. Bugert, Annika Y. Claßen et al. · Viruses · 2023 · 46 citations · Full text

Life Sciences, Biotechnology, Microbiology +16

Neurological symptoms and complications in predominantly hospitalized COVID‐19 patients: Results of the European multinational Lean European Open Survey on SARS‐Infected Patients (LEOSS)

Nina N. Kleineberg, Eileen Gülke, Hans O. Pinnschmidt et al. · European Journal of Neurology · 2021 · 34 citations · Full text

Medicine, Infectious Diseases, Neurology +10

Prediction of COVID-19 deterioration in high-risk patients at diagnosis: an early warning score for advanced COVID-19 developed by machine learning

Carolin Jakob, Ujjwal Mukund Mahajan, Marcus Oswald et al. · Infection · 2021 · 24 citations · Full text

Computing, Clinical Sciences, Infectious Diseases +17